Business Partners

Using a proprietary technology platform and competent management, Vectron Biosolutions AS s focuses on developing broad-host-range vector technology, especially expression vectors for industrial level production of recombinant proteins. In addition to providing innovative vector technology, Vectron Biosolutions AS offers its own life science research services, including recombinant protein production, vector development and molecular engineering of proteins and nucleic acids.

Based on competence and long-standing experience, Red Glead Discovery offers first-rate research services for drug discovery. In-house laboratory capabilities comprise medicinal chemistry, biology, analytical chemistry and ADME. An expert area is generation of chemical starting points for drug targets and to develop them into patentable lead compounds with drug-like properties and low risk profile. Our project management skills and cross-disciplinary capabilities make us a preferred partner for clients that want to develop compounds with high potential to become successful drugs.

XBrane Bioscience aims at simplifying your protein production - make it faster and easier. To this end, the company has developed two superior, versatile and easy to use systems for the production of proteins in E. coli, the Xbrane Lemo and Rhamex system. Furthermore, using the Xbrane OptiXpress approach we offer protein production, strain development and optimization services that are tailored around each individual target based on the wishes and needs of the customer.

inSili.com offers an elite source of intellectual property and unique expertise for innovative pharmaceutical and biotechnological research and development. The company provides know-how and world-leading technology for virtual screening of pioneering de novo designed molecular agents.
inSili.com's founders created and defined the terms "scaffold-hopping" and "frequent-hitters" in drug discovery. The company’s industry-proven molecular design concept is built on groundbreaking algorithms like CATS (Chemically Advanced Template Search) and DOGS (Design Of Genuine Structures) and a unique Collection Of Bioactive Reference Analogs (COBRA) for the discovery of new chemical entities featuring desired properties and tailored polypharmacology. inSili.com's unrivaled target prediction technique enables the "deorphaning" of bioactive agents like natural products and phenotypic screening hits. Own technology development and drug discovery projects continuously strengthen inSili.com's innovation potential.